Print

FEATURED NEWS

Results: 64 Articles found.
  • New Analysis Notes the Critical and Evolving Role Pharmaceutical Distributors Play in U.S. Healthcare
    July 30, 2019

    A new report published by the Healthcare Distribution Alliance (HDA) and Deloitte Consulting LLP highlights the value distributors provide to the United States healthcare ecosystem and estimates pharmaceutical distributors generate between $33 and $53 billion in cost savings annually. The Role of Distributors in the US Health Care Industry provides insights into the importance of wholesalers in driving efficiency and innovation across the pharmaceutical supply chain — both today and over the next several years.

  • What the ARCOS Data Won’t Tell You
    July 24, 2019

    Any discussion about ARCOS data must take into account the overall evolution of the prescription opioid epidemic and the complexity of the pharmaceutical supply chain.

  • HDA Statement on Release of DEA ARCOS Data
    July 16, 2019

    Healthcare Distribution Alliance (HDA) Senior Vice President of Communications John Parker released the following statement on the release of the Drug Enforcement Administration’s (DEA) Automation of Reports and Consolidated Orders System (ARCOS) data.

  • Analysis: Importation Policies Cost-Prohibitive to U.S. Healthcare System, Pose Risks to Patients
    July 15, 2019

    A new report published by the HDA Research Foundation concludes that federal proposals to permit the importation of prescription drugs into the U.S. fail to provide comprehensive guidance and funding to meet current federal safety and quality standards. As highlighted in the report, “The Risks and Realities of Commercial Drug Importation,” implementation of these policies would result in at least $1.1 billion in costs due to patient risks, required federal regulatory oversight and the operational challenges placed on the supply chain.

  • Fact Check: Where 60 Minutes Got it Wrong
    June 30, 2019

    60 Minutes has consistently presented misleading, inaccurate accounts of pharmaceutical distributors’ role in the opioid abuse crisis. The latest episode perpetuates a number of myths around the opioid epidemic and does a disservice to any effort to truly understand and address its root causes — notably, the shift in medical practice to treat pain more aggressively and the role of illegal drugs in most overdose deaths.

© 2019 Healthcare Distribution Alliance. All rights reserved.